Lianjin Biotech completes a Series A funding round of over RMB 300 million, led by Sherpa Investment
$STAR There's good news—could it drive the price up?
A single piece of news is unlikely to change the trend, but it could amplify volatility. How do you usually handle situations like this?

#STAR

It's your own money—think it through before you act.